XML 14 R5.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Class A Common Stock
Common Stock
Class V Common Stock
Accumulated Deficit
Accumulated Other Comprehensive Loss
Treasury Stock
Total Stockholders' Deficit Attributable to biote Corp.
Controlling Interest
Non Controlling Interest
Beginning balance at Dec. 31, 2022 $ (58,274) $ 1 $ 5 $ (44,460) $ (5)   $ (44,459) $ (13,815)  
Beginning balance, shares at Dec. 31, 2022   9,655,387 48,565,824            
Distributions (3,093)             (3,093)  
Net Loss (21,430)     (6,805)     (6,805) (14,625)  
Other comprehensive income (loss) 1             1  
Share-based compensation 2,170     2,170     2,170    
Vesting of RSUs       1,915 (4)   1,911 (1,911)  
Vesting of RSUs, shares   426,208              
Exercise of stock options 420     2,043 (3)   2,040 (1,620)  
Exercise of stock options, shares   105,049              
Litigation settlement 1,199     1,199     1,199    
Litigation settlement, shares   375,000              
Exchanges of Class V voting stock   $ 1 $ (1) 208     208 (208)  
Exchanges of Class V voting stock, shares   7,953,258 (7,953,258)            
TRA liability (4,802)     (4,802)     (4,802)    
Ending balance at Mar. 31, 2023 (83,809) $ 2 $ 4 (48,532) (12)   (48,538) (35,271)  
Ending balance, shares at Mar. 31, 2023   18,514,902 40,612,566            
Beginning balance at Dec. 31, 2022 (58,274) $ 1 $ 5 (44,460) (5)   (44,459) $ (13,815)  
Beginning balance, shares at Dec. 31, 2022   9,655,387 48,565,824            
Ending balance at Dec. 31, 2023 (36,546) $ 3 $ 3 (29,391) (12)   (29,397)   $ (7,149)
Ending balance, shares at Dec. 31, 2023   34,254,883 28,819,066            
Distributions (2,112)               (2,112)
Net Loss (5,810)     (2,070)     (2,070)   (3,740)
Other comprehensive income (loss) (5)       (2)   (2)   (3)
Share-based compensation 1,763     1,763     1,763    
Vesting of RSUs       (155)     (155)   155
Vesting of RSUs, shares   177,843              
Exercise of stock options 324     (1,831)     (1,831)   2,155
Exercise of stock options, shares   80,598              
Common stock repurchased (4,088)         $ (4,088) (4,088)    
Common stock repurchased, shares   (740,921)              
Shares issued in connection with acquisition 1,574     381     381   1,193
Shares issued in connection with acquisition, share   291,829              
Ending balance at Mar. 31, 2024 $ (44,900) $ 3 $ 3 $ (31,303) $ (14) $ (4,088) $ (35,399)   $ (9,501)
Ending balance, shares at Mar. 31, 2024   34,064,232 28,819,066